The originating document has been archived. We cannot confirm the completeness, accuracy, or currency of the content.
ULTRA Duramune DAP + 4L
This page contains information on ULTRA Duramune DAP + 4L for veterinary use.The information provided typically includes the following:
- ULTRA Duramune DAP + 4L Indications
- Warnings and cautions for ULTRA Duramune DAP + 4L
- Direction and dosage information for ULTRA Duramune DAP + 4L
ULTRA Duramune DAP + 4L
This treatment applies to the following species:Canine Distemper-Adenovirus Type 2-Parvovirus Vaccine
Modified Live Virus
Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract
For use in animals only
This product has been shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine distemper, infectious canine hepatitis, canine adenovirus type 2, canine parvovirus (CPV), Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae and Leptospira pomona. The duration of immunity for this product has not been determined. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.
This product contains a CPV 2b strain which has been demonstrated effective against disease caused by CPV 2c in puppies with CPV maternal antibody.
Directions For Use
● General directions: Aseptically rehydrate ULTRA Duramune DAP with low volume diluent supplied. Administer one 0.5 mL dose subcutaneously.
● Primary vaccination: The presence of maternal antibody is known to interfere with the development of active immunity in dogs and additional boosters will be required in most young animals.
All dogs should initially receive one dose of this product and a second dose 2 to 3 weeks later.
Historically, annual revaccination with a single dose has been recommended for this product. The need for this booster has not been established. For advice on revaccination frequency and annual booster vaccinations, consultation with a veterinarian is recommended.

ULTRA Duramune DAP + 4L Caution
Store in the dark at 2° to 8°C (35° to 46°F). AVOID FREEZING. SHAKE WELL. Do not mix with other products, except as specified on the label. This product has not been tested in pregnant animals. In case of anaphylactoid reaction, administer epinephrine. Inactivate all unused contents before disposal. In case of human exposure, contact a physician.
Gentamicin and thimerosal are added as preservatives.
ULTRA Duramune DAP + 4L Caution
In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.
Ultra, Duramune, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.
© 2017 Elanco US Inc. all rights reserved.
Elanco US Inc., Fort Dodge, IA 50501
Phone: 888-545-5973
VLN/PCN 196/47N9.20
25 Doses/25 Vials of Vaccine plus 25 x 0.5 mL Vials of Diluent |
YL101686X |
CPN: 1943018.2
Distributed by ELANCO US, INC.
2500 INNOVATION WAY, GREENFIELD, IN, 46140
Customer Service: | 317-276-1262 | |
Technical Service: | 800-428-4441 | |
Website: | www.elanco.us | |
Email: | elanco@elanco.com |
![]() |
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details. |
Copyright © 2025 Animalytix LLC. Updated: 2025-03-02